<DOC>
	<DOCNO>NCT02626013</DOCNO>
	<brief_summary>This non-interventional study aim assess impact nab-paclitaxel clinical outcome health-related QoL ( HRQoL ) heavily burden difficult-to-treat population . Notably , data generate context study serve complementary evidence tightly strictly control pre-registration clinical trial setting , essential importance especially patient population diseases complex heterogeneous biology , breast cancer .</brief_summary>
	<brief_title>A Multicenter , Prospective Cohort Study Provide Real-world Evidence Effect Nab-paclitaxel Treatment Clinical Outcomes Health-related Quality Life Patients With MBC Greece</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<criteria>Patients eligible inclusion study meet follow criterion : Adult patient ( 18 year old ) ; Patients histologically cytologically confirm diagnosis MBC fail firstline treatment metastatic disease standard , anthracycline contain therapy indicate ; Patients decision prescribe therapy nabpaclitaxel accord locally approve product 's summary product characteristic ( SmPC ) already take prior enrolment study ; assignment patient therapeutic strategy decide advance study protocol fall within current practice prescription nabpaclitaxel clearly separate physician 's decision include patient current study ; Patients must able willing provide write informed consent comply requirement study protocol ; Patients must sign informed consent document ; Patients must able read , understand complete study specific questionnaire A patient meet follow criterion exclude participation study : Patients initiated treatment nabpaclitaxel 7 day prior enrolment study ; Patients meet contraindication administration study drug accord approve SmPC ; Receipt investigational agent within 30 day 5 halflives investigational agent ( whichever longer ) commencement therapy nabpaclitaxel .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>